CLINICAL TRIALS PROFILE FOR ZETONNA
✉ Email this page to a colleague
All Clinical Trials for ZETONNA
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT01654536 ↗ | A 6 Month Safety Study Of Ciclesonide Nasal Aerosol (Zetonna®) And Ciclesonide Nasal Spray (Omnaris®) In Subjects 12 Years And Older With Perennial Allergic Rhinitis (PAR) | Completed | Sunovion | Phase 4 | 2012-09-01 | This is a 6 month, multicenter, randomized, open label, parallel group, study to evaluate the nasal safety of ciclesonide nasal aerosol and ciclesonide aqueous nasal spray administered once daily to male and female subjects 12 years and older diagnosed with PAR. |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for ZETONNA
Condition Name
Clinical Trial Locations for ZETONNA
Trials by Country
Clinical Trial Progress for ZETONNA
Clinical Trial Phase
Clinical Trial Sponsors for ZETONNA
Sponsor Name